Market Cap

Virbac SA Market Capitalization:

€2.58 Billion

EUR as of Jan. 1, 2025

US$2.68 Billion

business Virbac SA Company Profile

Virbac SA Main Stock Listing

Euronext: VIRP

Market Capitalization History of Virbac SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $689.42 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B
Merck $244.44 B
Roche $219.35 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Yearly evolution of Virbac SA market cap

Date Market Cap YoY Change
Jan. 1, 2025 €2.58 B -12.62%
Jan. 1, 2024 €2.95 B 47.59%
Jan. 1, 2023 €2.00 B -33.47%
Jan. 1, 2022 €3.00 B 65.73%
Jan. 1, 2021 €1.81 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Virbac SA Categories

France languages Healthcare languages Drug Manufacturers—General
France Healthcare France Drug Manufacturers—General

Stocks & Indices

Virbac SA has the following listings and related stock indices.


Stock: Euronext: VIRP

Stock: FSX: V16

Stock: OTC: VRBCF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.